GlaxoSmithKline Sees Light at End of Advair Tunnel GlaxoSmithKline Sees Light at End of Advair Tunnel

GlaxoSmithKline sees growth strengthening over the next few years as the drugmaker weathers increased competition in its core respiratory and HIV businesses that could cause earnings to dip this year.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news